RxDoctor Payments Data

Santiago Ortega Gutierrez, MD

Vascular & Interventional Radiology · Iowa City, IANPI 1629148010

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Stryker at 59.7% of the total. Among vascular & interventional radiology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$628,489in general payments, 2019–2025

Across 442 payments — averaging $1421.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$375K
  • Medtronic$224K
  • Medical Device Business Services, Inc.$22K
  • Microvention, Inc.$6K
  • Siemens Medical Solutions USA, Inc.$730
  • Viz.ai, Inc.$611
  • plus $380 from 6 others
$599,755in research payments, 2019–2025

Across 33 payments — averaging $18,174 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$330K
  • Siemens Medical Solutions USA, Inc.$186K
  • Microvention, Inc.$50K
  • Route 92 Medical, Inc.$33K

What the payments were for

  • Consulting fees$356,27157%
  • Speaking & faculty fees$172,85028%
  • Travel & lodging$91,46615%
  • Food & beverage$7,9031%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$628,489 in reported general payments places this provider in the 95th percentile of 34 vascular & interventional radiology providers in Iowa.

See all vascular & interventional radiology providers in Iowa

Medicare billing

Part B allowed, 2024
$92,237
Medicare patients
107
Services billed
408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor21$12,537
ClopidogrelClopidogrel Bisulfate27$213
Atorvastatin Calcium22$202

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →